
- Image via Wikipedia
The genetic marker KIF6 has been found to not be predictive for coronary artery disease in a large replication study.
Researchers found in the study that mutations in the KIF6 gene were not associated with the development of coronary artery disease. Because this was such a large study, the researchers expected that if there was a connection between coronary artery disease and the genetic marker, it would have been found during the analysis.
The researchers looked at 19 case-control studies that included 17,000 cases and 39,369 controls with the vast majority of the patients being of European descent. There were some African Americans, South Asians and Hispanics included in the analysis. The researchers found that none of the 19 studies analyzed showed an higher risk of coronary artery disease in people with the 719Arg allele mutation of the KIF6 gene when compared with people without the allele. There were no associations found in the various ethnic groups as well.
Mutations in the KIF6 gene had previously been shown to be associated with an increased risk of coronary artery disease. Other studies found that patients who would benefit from treatment with statin medications to lower this risk.
The earlier studies which found the associations with the KIF6 gene and coronary artery disease were funded by the biotech company Celera which was a key player in the Human Genome Project. Celera issued a press release disputing the findings of the most recent trial in that the new data does not disprove the association with coronary artery disease.
The scientists associated with the current study acknowledge that the results of the study may be limited by the fact that they evaluated only non-fatal cases of coronary artery disease and that if the mutation is more related to fatal effects of heart disease, it would not show up during the evaluation. However, these researcher stand by their findings and suggest more research is needed.














